BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shen Y, Shi Z, Yan B. Carboxylesterases: Pharmacological Inhibition Regulated Expression and Transcriptional Involvement of Nuclear Receptors and other Transcription Factors. Nuclear Receptor Research 2019;6. [DOI: 10.32527/2019/101435] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Yerrakula G, George SG, Abraham S, Zeharvi M, John S, Senthil V, Maiz F, Rahman MH. Major implications of single nucleotide polymorphisms in human carboxylesterase 1 on substrate bioavailability. Biotechnol Genet Eng Rev 2022;:1-19. [PMID: 35946821 DOI: 10.1080/02648725.2022.2108997] [Reference Citation Analysis]
2 Kumar SP, Sherpa DD, Sahu AK, Jadav T, Tekade RK, Sengupta P. Innovation in bioanalytical strategies and in vitro drug-drug interaction study approaches in drug discovery. Bioanalysis 2021;13:513-32. [PMID: 33682424 DOI: 10.4155/bio-2021-0001] [Reference Citation Analysis]
3 Shinha K, Nihei W, Ono T, Nakazato R, Kimura H. A pharmacokinetic–pharmacodynamic model based on multi-organ-on-a-chip for drug–drug interaction studies. Biomicrofluidics 2020;14:044108. [DOI: 10.1063/5.0011545] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]